Glucocorticoid in giant cell arteritis: real-world treatment patterns over time and associated burden in a nationwide hospital-based study within the French health insurance database

database[Title] 2026-07-09

Summary:

CONCLUSION: Despite reductions in high-dose use, cumulative GC exposure in GCA remains substantial and associated with adverse outcomes, even at the lowest doses.

Link:

https://pubmed.ncbi.nlm.nih.gov/42414038/?utm_source=Other&utm_medium=rss&utm_campaign=pubmed-2&utm_content=12QQbiNmM99eUQGIX1JjHIKcROC1Vzv4sOS-2S_LNI19uG_Yrk&fc=20220129225649&ff=20260709035624&v=2.20.0

From feeds:

📚BioDBS Bibliography » database[Title]

Authors:

Maxime Beydon, Diane Lacaille, Bruno Fautrel, Raphaèle Seror, David Hajage, Florence Tubach

Date tagged:

07/09/2026, 03:56

Date published:

07/07/2026, 06:00